Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Therneau

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Controlled Clinical Trials|March 1, 1987
A two-stage design for randomized trials with binary outcomesS Wieand, T Therneau
Leukemia & Lymphoma|August 28, 1998
Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemiaT E Witzig, T Kimlinger, M Stenson, et al.
Leukemia & Lymphoma|June 1, 2000
A prospective study of CD38/45 flow cytometry and immunofluorescence microscopy to detect blood plasma cells in patients with plasma cell proliferative disordersT E Witzig, C Meyers, T Therneau, et al.
Lancet (London, England)|March 4, 2000
Ursodeoxycholic acid for primary biliary cirrhosisK D Lindor, R Poupon, R Poupon, et al.
British Journal of Haematology|February 23, 1999
Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disordersT E Witzig, M Timm, D Larson, et al.
Hepatology (Baltimore, Md.)|May 15, 1998
Cost-effectiveness of ultrasound-guided liver biopsyT Pasha, S Gabriel, T Therneau, et al.
Cancer|August 15, 1990
A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostateS R Patel, L K Kvols, R G Hahn, et al.
The Journal of Urology|November 1, 1989
Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidyM L Blute, O Nativ, H Zincke, et al.
Hepatology (Baltimore, Md.)|September 10, 1998
TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosisM Charlton, P Adjei, J Poterucha, et al.
Cardiovascular Drugs and Therapy|August 1, 1987
The mortality risk associated with digitalis treatment after myocardial infarction, A J Moss, J T Bigger, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Controlled Clinical Trials|March 1, 1987
A two-stage design for randomized trials with binary outcomesS Wieand, T Therneau
Leukemia & Lymphoma|August 28, 1998
Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemiaT E Witzig, T Kimlinger, M Stenson, et al.
Leukemia & Lymphoma|June 1, 2000
A prospective study of CD38/45 flow cytometry and immunofluorescence microscopy to detect blood plasma cells in patients with plasma cell proliferative disordersT E Witzig, C Meyers, T Therneau, et al.
Lancet (London, England)|March 4, 2000
Ursodeoxycholic acid for primary biliary cirrhosisK D Lindor, R Poupon, R Poupon, et al.
British Journal of Haematology|February 23, 1999
Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disordersT E Witzig, M Timm, D Larson, et al.
Hepatology (Baltimore, Md.)|May 15, 1998
Cost-effectiveness of ultrasound-guided liver biopsyT Pasha, S Gabriel, T Therneau, et al.
Cancer|August 15, 1990
A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostateS R Patel, L K Kvols, R G Hahn, et al.
The Journal of Urology|November 1, 1989
Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidyM L Blute, O Nativ, H Zincke, et al.
Hepatology (Baltimore, Md.)|September 10, 1998
TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosisM Charlton, P Adjei, J Poterucha, et al.
Cardiovascular Drugs and Therapy|August 1, 1987
The mortality risk associated with digitalis treatment after myocardial infarction, A J Moss, J T Bigger, et al.
Pageof 2